Diffusion‐weighted <scp>MRI</scp> for hepatocellular carcinoma screening in chronic liver disease: Direct comparison with ultrasound screening

Abstract

In patients with chronic liver disease undergoing surveillance for hepatocellular carcinoma, DWI MRI screening shows similar sensitivity to screening ultrasound but with a significantly lower false-positive rate.